Keyword Connections

anti-infective agents / pharmacology*

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

13

1 Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

2 In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli

3 Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

4 Factors influencing fluoroquinolone resistance

5 Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds

6 Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

7 Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team

8 Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

9 Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

10 Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation

11 Emergence of multidrug-resistant Salmonella typhi in rural southern India

12 Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status

13 Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial